Consistent with our research results, it was reported that expression of MYH9 is closely related to the malignant degree of cancer, and can be regarded as a marker for evaluating lymph node metastasis and poor prognosis in breast cancer 16, epithelial ovarian cancer 17 and acute myeloid leukemia 18. Here, MYH9 is linked to breast carcinoma.